Diagnostic Testing

The statistics are grim, and among certain populations are getting even worse. It’s estimated that close to 160,000 Americans will be diagnosed with colorectal cancer (CRC) this year, and over 55,000 deaths will occur because of CRC. While cases are declining among those 65 and older, largely due to screening,…

You may remember that the FDA has now approved 2 different medications to help slow down the progression of Alzheimer’s in patients who are in the early stages of the disease. Those are Leqembi and Kisunla. While neither can cure or reverse Alzheimer’s dementia, and they both come with potentially…

You may remember that, back in November, we reported on the emergence of additional blood biomarker tests for Alzheimer’s that, while not actually giving you an Alzheimer’s diagnosis, would be able to rule out one of the proteins highly predictive of Alzheimer’s in patients who are experiencing worrisome symptoms. In…

As we end Heart Health month and perhaps renew our pledge to do all we can to lower our risk of heart disease (which continues to be the #1 cause of death in our country), there’s no getting around the risk that high cholesterol poses to our heart health. While…

You walk into a room in your house and promptly forget why you did so. Or you start an online purchase and forget your zipcode when prompted. Or maybe you’re out running an errand and momentarily forget the name of the acquaintance you bump into. Are you losing your mind?…

You may remember past agebuzz posts describing the emergence of blood tests that, in conjunction with clinical assessments, can be used to diagnose Alzheimer’s disease. Last spring, the FDA approved the Lumipulse blood test for adults aged 55 and older, who, when attending specialty clinics, could use the blood test…